programmed cell death inhibitor (Johns Hopkins University)

N/A

Report date: 2025/03/20 09:49:58

Base Information

Drug Nameprogrammed cell death inhibitor (Johns Hopkins University)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNerve DegenerationAutoimmune DiseasesNeoplasms +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesJohns Hopkins University
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsNerve DegenerationAutoimmune DiseasesNeoplasms +[4
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A